In our study, pentamer staining revealed beta-gal epitope specific CD8+ T lymphocytes in treated mice, and the cytotoxic assay and rechallenge examination also showed systemic tumor-specific immune response of CD8+ T lymphocytes. Here, CD8A is linked to neoplasm.